


How to Conduct a Mid-Year Self-Review
Guest Post from Sylvia Wambui – Black Women in Clinical Research A mid-year review is a chance to step back and take notes of the hits, misses, and learning from the past 6 months and plan how many milestones you need to take in front of you. A review will not only...
The Evolution and Continued Success of TMF University
LMK recognized a void in the area of educational excellence and regulatory knowledge surrounding the management of the TMF in the clinical trial space. While there are many webinars and conferences related to TMF, most provide only foundational knowledge and do not...
Competence and Clinical Research
A word that is finding increasing use in the clinical research sector is competence. But what does it mean and what is its significance? Competence can be defined as the ability of an individual to demonstrate knowledge, skills and behaviours. When someone is...
Recent Announcement Reveals Supply Chain Risk to Clinical Trials & Patients
Accreditation isn’t expensive, the cost of ICH-GCP violations is! Could the Pfizer / Valneva issue happen to your trial? In 2021 the FDA reported: 36% of all clinical trials fail 51% of clinical trials fail to follow the investigational plan Considering these...
Spotlight on Leadership: Sholeh Ehdaivand, Founder, President & CEO at LMK Clinical Research
Sholeh Ehdaivand has worked in clinical research for over 20 years and has a true passion for making a difference in people’s lives by aiding the development of newer, better healthcare solutions. Having launched LMK eight years ago, the business has continued to grow...
GCP violations lead to Global Leading Pharma Company’s Phase III Trial Discontinuation
Pfizer and Valneva have recently announced the discontinuation of a significant percentage of participants in the U.S. who had been enrolled in the Vaccine Against Lyme for Outdoor Recreationists (VALOR). The rationale for the discontinuation of this Phase III...
Why do Clinical Trial Site Inspections Fail? Reducing Risk and Assuring Quality in Clinical Research
Clinical research is the fastest growing industry in the world worth US$ 49.8 billion in 2022 which is estimated to reach a staggering US$ 84.43 billion by 2030 (ref. Global Newswire). And yet over the past five years the FDA has reported a failure rate of 36% in...
Disease and Illness Do Not Discriminate: Diversity in Clinical Trials
Guest Post from Dr Suki Balendra, Life Sciences Lead, Imperial College Healthcare NHS Trust Patient diversity in clinical trials has long been a topic of discussion within the research community. Disease and illness of course do not discriminate, but our age, race and...
The Northern Research Diamond: Where nature, innovation and research change the world!
Guest Post from Dace Dimza-Jones – Industry Facilitator, NIHR Clinical Research Network Greater Manchester My concept of the Northern Research Diamond was born out of observing established links within the region, and further grounded by the history and the impact it...
IAOCR demonstrates ongoing commitment to quality
Quality is the backbone of what IAOCR strives to deliver both directly and by supporting the Clinical Research Industry. As part of our ongoingcommitment to the Industry, we have bolstered our team with the addition of Sarah Everitt who is our new Vice President of...
IAOCR means…
IAOCR has been committed to transforming the world of clinical research for over a decade. Driving this through the adoption of global best-practice standards for the enhancement and advancement of people and processes in the clinical research industry. This is...